Related references
Note: Only part of the references are listed.The effect of injection duration and injection site on pain and bruising of subcutaneous injection of heparin
Tayebe Pourghaznein et al.
JOURNAL OF CLINICAL NURSING (2014)
Higher incidence of injection site reactions after subcutaneous bortezomib administration on the thigh compared with the abdomen
Tomohiko Kamimura et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2013)
No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease
Kevin E. Chan et al.
KIDNEY INTERNATIONAL (2013)
Immunogenicity, Safety, and Efficacy of Abatacept Administered Subcutaneously With or Without Background Methotrexate in Patients With Rheumatoid Arthritis: Results From a Phase III, International, Multicenter, Parallel-Arm, Open-Label Study
Peter Nash et al.
ARTHRITIS CARE & RESEARCH (2013)
Comparative injection-site pain and tolerability of subcutaneous serum-free formulation of interferonβ-1a versus subcutaneous interferonβ-1b: results of the randomized, multicenter, Phase IIIb REFORMS study
Barry Singer et al.
BMC NEUROLOGY (2012)
Patients' Perceptions of Subcutaneous Delivery of Darbepoetin Alfa by Autoinjector Prefilled Pen Versus Prefilled Syringe: A Randomized, Crossover Study
Wai H. Lim et al.
CLINICAL THERAPEUTICS (2012)
The Role of Comfort and Discomfort in Insulin Therapy
Ronnie Aronson
DIABETES TECHNOLOGY & THERAPEUTICS (2012)
Inflammatory skin responses induced by icatibant injection are mast cell mediated and attenuated by H1-antihistamines
Marcus Maurer et al.
EXPERIMENTAL DERMATOLOGY (2012)
The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis
V. Devonshire et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
New injection recommendations for patients with diabetes
A. Frid et al.
DIABETES & METABOLISM (2010)
Correlates of Insulin Injection Omission
Mark Peyrot et al.
DIABETES CARE (2010)
Tolerability and safety of novel half milliliter formulation of glatiramer acetate for subcutaneous injection: an open-label, multicenter, randomized comparative study
G. Anderson et al.
JOURNAL OF NEUROLOGY (2010)
Trends in RA patients' adherence to subcutaneous anti-TNF therapies and costs
Bijan J. Borah et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
A Comparison of Insulin Injection Needles on Patients' Perceptions of Pain, Handling, and Acceptability: A Randomized, Open-Label, Crossover Study in Subjects with Diabetes
Maureen McKay et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2009)
Clinical assessment of pain, tolerability, and preference of an autoinjection pen versus a prefilled syringe for patient self-administration of the fully human, monoclonal antibody adalimumab: The TOUCH trial
Alan Kivitz et al.
CLINICAL THERAPEUTICS (2006)
Effects of subcutaneous administration of glutamate on pain, sensitization and vasomotor responses in healthy men and women
Parisa Gazerani et al.
PAIN (2006)
Pain perception after subcutaneous injections of media containing different buffers
T Laursen et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2006)
The positive and negative affect schedule (PANAS): Construct validity, measurement properties and normative data in a large non-clinical sample
JR Crawford et al.
BRITISH JOURNAL OF CLINICAL PSYCHOLOGY (2004)
Effects of injection duration on site-pain intensity and bruising associated with subcutaneous heparin
H Chan
JOURNAL OF ADVANCED NURSING (2001)
Share Paper
